Home > Research > Publications & Outputs > Assessing systemic drug exposure in repeated do...
View graph of relations

Assessing systemic drug exposure in repeated dose toxicity studies in the case of complete and incomplete sampling.

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Published

Standard

Assessing systemic drug exposure in repeated dose toxicity studies in the case of complete and incomplete sampling. / Wolfsegger, Martin J.; Jaki, Thomas.
In: Biometrical Journal, Vol. 51, No. 6, 12.2009, p. 1017-1026.

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Harvard

APA

Vancouver

Wolfsegger MJ, Jaki T. Assessing systemic drug exposure in repeated dose toxicity studies in the case of complete and incomplete sampling. Biometrical Journal. 2009 Dec;51(6):1017-1026. doi: 10.1002/bimj.200900151

Author

Wolfsegger, Martin J. ; Jaki, Thomas. / Assessing systemic drug exposure in repeated dose toxicity studies in the case of complete and incomplete sampling. In: Biometrical Journal. 2009 ; Vol. 51, No. 6. pp. 1017-1026.

Bibtex

@article{f773575141d4424183c5cab4a407d797,
title = "Assessing systemic drug exposure in repeated dose toxicity studies in the case of complete and incomplete sampling.",
abstract = "Repeated dose toxicity studies are performed to characterize the toxicological profile of a test compound following repeated administrations. The findings and interpretations from these systemic exposure studies in animals are essential for designing subsequent studies and evaluating the safety of the test item for humans. Blood samples for assessment of systemic exposure are usually collected on day one and at the end of the study with multiple dosings of the compound in between. Restrictions in blood volume often require an incomplete sampling design, in which each animal contributes sample measurements at some but not all time points. In this manuscript we derive an estimator for the ratio of area under the concentration versus time curves (AUCs), a frequently used measure of exposure to a compound, and a corresponding confidence interval to assess differences in exposure as well as equivalence between first and repeated administration that is applicable in such sparse sampling designs as well as complete data situations. An illustrative example is provided and the statistical properties of the proposed estimator, which incorporates the dependencies of measurements between first and repeated dosings as well as the dependency inherent in repeated sampling for each dosing, is studied asymptotically as well as in simulation.",
keywords = "AUC • Batch design • Repeated dosing • Sparse sampling • Toxicology",
author = "Wolfsegger, {Martin J.} and Thomas Jaki",
year = "2009",
month = dec,
doi = "10.1002/bimj.200900151",
language = "English",
volume = "51",
pages = "1017--1026",
journal = "Biometrical Journal",
issn = "1521-4036",
publisher = "Wiley-VCH Verlag",
number = "6",

}

RIS

TY - JOUR

T1 - Assessing systemic drug exposure in repeated dose toxicity studies in the case of complete and incomplete sampling.

AU - Wolfsegger, Martin J.

AU - Jaki, Thomas

PY - 2009/12

Y1 - 2009/12

N2 - Repeated dose toxicity studies are performed to characterize the toxicological profile of a test compound following repeated administrations. The findings and interpretations from these systemic exposure studies in animals are essential for designing subsequent studies and evaluating the safety of the test item for humans. Blood samples for assessment of systemic exposure are usually collected on day one and at the end of the study with multiple dosings of the compound in between. Restrictions in blood volume often require an incomplete sampling design, in which each animal contributes sample measurements at some but not all time points. In this manuscript we derive an estimator for the ratio of area under the concentration versus time curves (AUCs), a frequently used measure of exposure to a compound, and a corresponding confidence interval to assess differences in exposure as well as equivalence between first and repeated administration that is applicable in such sparse sampling designs as well as complete data situations. An illustrative example is provided and the statistical properties of the proposed estimator, which incorporates the dependencies of measurements between first and repeated dosings as well as the dependency inherent in repeated sampling for each dosing, is studied asymptotically as well as in simulation.

AB - Repeated dose toxicity studies are performed to characterize the toxicological profile of a test compound following repeated administrations. The findings and interpretations from these systemic exposure studies in animals are essential for designing subsequent studies and evaluating the safety of the test item for humans. Blood samples for assessment of systemic exposure are usually collected on day one and at the end of the study with multiple dosings of the compound in between. Restrictions in blood volume often require an incomplete sampling design, in which each animal contributes sample measurements at some but not all time points. In this manuscript we derive an estimator for the ratio of area under the concentration versus time curves (AUCs), a frequently used measure of exposure to a compound, and a corresponding confidence interval to assess differences in exposure as well as equivalence between first and repeated administration that is applicable in such sparse sampling designs as well as complete data situations. An illustrative example is provided and the statistical properties of the proposed estimator, which incorporates the dependencies of measurements between first and repeated dosings as well as the dependency inherent in repeated sampling for each dosing, is studied asymptotically as well as in simulation.

KW - AUC • Batch design • Repeated dosing • Sparse sampling • Toxicology

U2 - 10.1002/bimj.200900151

DO - 10.1002/bimj.200900151

M3 - Journal article

VL - 51

SP - 1017

EP - 1026

JO - Biometrical Journal

JF - Biometrical Journal

SN - 1521-4036

IS - 6

ER -